Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo.

MLA

Shannon L Kordus, et al. “Nanobodies against C. Difficile TcdA and TcdB Reveal Unexpected Neutralizing Epitopes and Provide a Toolkit for Toxin Quantitation in Vivo.” PLoS Pathogens, vol. 19, no. 10, Oct. 2023, p. e1011496. EBSCOhost, https://doi.org/10.1371/journal.ppat.1011496&type=printable.

APA

Shannon L Kordus, Heather K Kroh, Rubén Cano Rodríguez, Rebecca A Shrem, F Christopher Peritore-Galve, John A Shupe, Brian E Wadzinski, D Borden Lacy, & Benjamin W Spiller. (2023). Nanobodies against C. difficile TcdA and TcdB reveal unexpected neutralizing epitopes and provide a toolkit for toxin quantitation in vivo. PLoS Pathogens, 19(10), e1011496. https://doi.org/10.1371/journal.ppat.1011496&type=printable

Chicago

Shannon L Kordus, Heather K Kroh, Rubén Cano Rodríguez, Rebecca A Shrem, F Christopher Peritore-Galve, John A Shupe, Brian E Wadzinski, D Borden Lacy, and Benjamin W Spiller. 2023. “Nanobodies against C. Difficile TcdA and TcdB Reveal Unexpected Neutralizing Epitopes and Provide a Toolkit for Toxin Quantitation in Vivo.” PLoS Pathogens 19 (10): e1011496. doi:10.1371/journal.ppat.1011496&type=printable.